{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:42:47Z","timestamp":1791855767324,"version":"4.3.4"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05991-w","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:30:10Z","timestamp":1781083810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson\u2019s and Huntington\u2019s Disease: Molecular Insights and Emerging Interventions"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1796-4913","authenticated-orcid":false,"given":"Omkar Kumar","family":"Kuwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarila","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Maloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta Sachdeva","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"5991_CR1","doi-asserted-by":"publisher","unstructured":"Kuwar OK, Tejpal S, Sharma V et al (2026) Therapeutic potential of sulforaphane in neurodegenerative diseases: mechanistic Insights into Nrf2, NF-\u03baB, TrkB, SIRT1, MAPK, and JAK\/STAT signalling pathways. Mol Biol Rep 53:553. https:\/\/doi.org\/10.1007\/s11033-026-11729-7","DOI":"10.1007\/s11033-026-11729-7"},{"key":"5991_CR2","doi-asserted-by":"publisher","first-page":"1621070","DOI":"10.3389\/fnmol.2025.1621070","volume":"18","author":"T Feofilaktova","year":"2025","unstructured":"Feofilaktova T et al (2025) Calcium signaling in postsynaptic mitochondria: mechanisms, dynamics, and role in ATP production. Front Mol Neurosci 18:1621070","journal-title":"Front Mol Neurosci"},{"key":"5991_CR3","doi-asserted-by":"publisher","unstructured":"Lin YH, Lin KJ, Shao IH (2025) The critical role of mitochondrial dysfunction in ADT-induced neurotoxicity. Prostate Cancer Prostatic Dis 28:1013\u20131014. https:\/\/doi.org\/10.1038\/s41391-025-00958-9","DOI":"10.1038\/s41391-025-00958-9"},{"issue":"12","key":"5991_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.neuron.2022.03.015","volume":"110","author":"X-T Cheng","year":"2022","unstructured":"Cheng X-T, Huang N, Sheng Z-H (2022) Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration. Neuron 110(12):1899\u20131923","journal-title":"Neuron"},{"key":"5991_CR5","doi-asserted-by":"crossref","unstructured":"Heger Lea et al (2021) Mitochondrial phenotypes in Parkinson\u2019s diseases\u2014a focus on human iPSC-derived dopaminergic neurons. Cells 10(12):3436","DOI":"10.3390\/cells10123436"},{"issue":"19","key":"5991_CR6","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.3390\/ijms231911391","volume":"23","author":"V Bazzani","year":"2022","unstructured":"Bazzani V et al (2022) Mitochondrial DNA repair in neurodegenerative diseases and ageing. Int J Mol Sci 23(19):11391","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5991_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.14336\/ad.2020.0331","volume":"12","author":"Mea Ke","year":"2021","unstructured":"Ke Mea et al (2021) Comprehensive perspectives on experimental models for Parkinson\u2019s disease. Aging Dis 12(1):223","journal-title":"Aging Dis"},{"key":"5991_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-981-97-5742-8_6","volume-title":"Preclinical cancer models for translational research and drug development","author":"Y Muralidaran","year":"2025","unstructured":"Muralidaran Y et al (2025) Higher-order in vitro models of dysregulated bioenergetics mechanisms and drug development. Preclinical cancer models for translational research and drug development. Springer, pp 129\u2013151"},{"key":"5991_CR9","doi-asserted-by":"publisher","unstructured":"Kalia N, Kuwar OK (2026) Methamphetamine-driven neuroinflammation and parkinson\u2019s disease pathology: Mechanistic insight into Nrf2 and NF\u0138B signaling. Mol Neurobiol 63:365.\u00a0https:\/\/doi.org\/10.1007\/s12035-026-05674-6","DOI":"10.1007\/s12035-026-05674-6"},{"key":"5991_CR10","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1007\/s10787-025-01846-3","volume":"33","author":"K Mahto","year":"2025","unstructured":"Mahto K, Kuwar OK, Maloo A et al (2025) Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF\u0138B, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis. Inflammopharmacol 33:5011\u20135021. https:\/\/doi.org\/10.1007\/s10787-025-01846-3","journal-title":"Inflammopharmacol"},{"key":"5991_CR11","doi-asserted-by":"publisher","unstructured":"Lin Y, Li C, Chen Y et al (2025) RNA-Targeting CRISPR\/CasRx system relieves disease symptoms in Huntington\u2019s disease models. Mol Neurodegeneration 20:4. https:\/\/doi.org\/10.1186\/s13024-024-00794-w","DOI":"10.1186\/s13024-024-00794-w"},{"issue":"1","key":"5991_CR12","doi-asserted-by":"publisher","first-page":"2400023","DOI":"10.1002\/bies.202400023","volume":"47","author":"ZP Van Acker","year":"2025","unstructured":"Van Acker ZP, Leroy T, Annaert W (2025) Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases? BioEssays 47(1):2400023","journal-title":"BioEssays"},{"issue":"19","key":"5991_CR13","doi-asserted-by":"publisher","first-page":"9643","DOI":"10.3390\/ijms26199643","volume":"26","author":"AF Murillo-Cancho","year":"2025","unstructured":"Murillo-Cancho AF, Lozano-Paniagua D, Nievas-Soriano BJ (2025) Dietary and pharmacological modulation of aging-related metabolic pathways: molecular insights, clinical evidence, and a translational model. Int J Mol Sci 26(19):9643","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5991_CR14","doi-asserted-by":"publisher","first-page":"e70086","DOI":"10.1002\/jcp.70086","volume":"240","author":"A Gervasi","year":"2025","unstructured":"Gervasi A et al (2025) Connexin 43 role in mitochondrial transfer and homeostasis in the central nervous system. J Cell Physiol 240(8):e70086","journal-title":"J Cell Physiol"},{"issue":"1","key":"5991_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","volume":"23","author":"S Li","year":"2022","unstructured":"Li S, Sheng Z-H (2022) Energy matters: presynaptic metabolism and the maintenance of synaptic transmission. Nat Rev Neurosci 23(1):4\u201322","journal-title":"Nat Rev Neurosci"},{"key":"5991_CR16","doi-asserted-by":"crossref","unstructured":"Li Cea et al (2025) Update on the correlation between mitochondrial function and osteonecrosis of the femoral head osteocytes. Redox Rep 30(1):2491846","DOI":"10.1080\/13510002.2025.2491846"},{"issue":"9","key":"5991_CR17","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.4103\/NRR.NRR-D-25-00368","volume":"21","author":"A Parikh","year":"2025","unstructured":"Parikh A, Cholavaram A, Babu AK, Deepankumar K, Vijayan M (2025) Role of voltage-dependent anion channel 1 in neurodegeneration: Mechanisms, implications, and therapeutic potential. Neural Regen Res 3:10\u20134103","journal-title":"Neural Regen Res"},{"key":"5991_CR18","doi-asserted-by":"publisher","unstructured":"Casey AM, Ryan DG, Prag HA et al (2025) Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1\u03b2 release during NLRP3 inflammasome activation. Nat Metab 7:493\u2013507.\u00a0https:\/\/doi.org\/10.1038\/s42255-025-01224-x","DOI":"10.1038\/s42255-025-01224-x"},{"issue":"1","key":"5991_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-025-02032-2","volume":"23","author":"Y Yoo","year":"2025","unstructured":"Yoo Y et al (2025) Role of cardiolipin in skeletal muscle function and its therapeutic implications. Cell Commun Signal 23(1):36","journal-title":"Cell Commun Signal"},{"key":"5991_CR20","doi-asserted-by":"publisher","unstructured":"Protasoni M, Zeviani M (2021) Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions. Int J Mol Sci 22(2):586.\u00a0https:\/\/doi.org\/10.3390\/ijms22020586","DOI":"10.3390\/ijms22020586"},{"key":"5991_CR21","first-page":"10","volume":"19","author":"KA Cicali","year":"2025","unstructured":"Cicali KA, Torres AK, Tapia-Rojas C (2025) Synaptic mitochondria in aging and neurodegenerative diseases: unraveling their functional decline and vulnerability. Neural Regen Res 19:10\u20134103","journal-title":"Neural Regen Res"},{"issue":"8","key":"5991_CR22","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/biomedicines13082025","volume":"13","author":"V Voicu","year":"2025","unstructured":"Voicu V et al (2025) Systemic neurodegeneration and brain aging: multi-omics disintegration, proteostatic collapse, and network failure across the CNS. Biomedicines 13(8):2025","journal-title":"Biomedicines"},{"key":"5991_CR23","doi-asserted-by":"crossref","unstructured":"Stowe DF (2025) Mitochondrial function and bioenergetics. Evolution of bioenergetics from elements to life: emergence of high energy mitochondria. Springer, pp 123\u2013156","DOI":"10.1007\/978-3-031-76668-8_5"},{"issue":"3","key":"5991_CR24","doi-asserted-by":"publisher","first-page":"e70026","DOI":"10.1002\/mef2.70026","volume":"4","author":"L Jia","year":"2025","unstructured":"Jia L et al (2025) Mitochondrial dysfunction in aging: future therapies and precision medicine approaches. MedComm-Future Med 4(3):e70026","journal-title":"MedComm-Future Med"},{"key":"5991_CR25","first-page":"50","volume":"1","author":"N Anjum","year":"2025","unstructured":"Anjum N, Deshmukh D, Deshmukh N, Sahu B, Kasar I (2025) The consequences of mitochondrial DNA mutation on neurodegenerative diseases. J Pharmacol Genet Mol Biol 1:50\u201364","journal-title":"J Pharmacol Genet Mol Biol"},{"issue":"17","key":"5991_CR26","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.3390\/ijms26178693","volume":"26","author":"A Dominiak","year":"2025","unstructured":"Dominiak A et al (2025) Mitochondrial quality control in neurodegeneration and cancer: a common denominator, distinct therapeutic challenges. Int J Mol Sci 26(17):8693","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5991_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00018-024-05556-x","volume":"82","author":"W Xu","year":"2025","unstructured":"Xu W et al (2025) The interconnective role of the UPS and autophagy in the quality control of cancer mitochondria. Cell Mol Life Sci 82(1):42","journal-title":"Cell Mol Life Sci"},{"key":"5991_CR28","doi-asserted-by":"publisher","unstructured":"Attri M, Kuwar OK (2026) The KEAP1-Cullin3-RBX1-Nrf2 axis in redox homeostasis: Molecular mechanisms, pathophysiological roles, and precision therapeutic opportunities. Mol Neurobiol 63:15. https:\/\/doi.org\/10.1007\/s12035-025-05313-6","DOI":"10.1007\/s12035-025-05313-6"},{"key":"5991_CR29","doi-asserted-by":"publisher","unstructured":"Ludwig K, Heidorn-Czarna M (2025) Mitochondrial proteases and their roles in mitophagy in plants, animals, and yeast. Plant and Cell Physiol 66(7):973\u2013990.\u00a0https:\/\/doi.org\/10.1093\/pcp\/pcaf038","DOI":"10.1093\/pcp\/pcaf038"},{"key":"5991_CR30","doi-asserted-by":"crossref","unstructured":"Zanfardino Pea et al (2025) The balance of MFN2 and OPA1 in mitochondrial dynamics, cellular homeostasis, and disease. Biomolecules 15(3):433","DOI":"10.3390\/biom15030433"},{"issue":"3","key":"5991_CR31","doi-asserted-by":"publisher","first-page":"26458","DOI":"10.31083\/JIN26458","volume":"24","author":"Y Ma","year":"2025","unstructured":"Ma Y et al (2025) Mechanisms associated with mitophagy and ferroptosis in cerebral ischemia-reperfusion injury. J Integr Neurosci 24(3):26458","journal-title":"J Integr Neurosci"},{"issue":"4","key":"5991_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","volume":"24","author":"O Antico","year":"2025","unstructured":"Antico O et al (2025) Targeting mitophagy in neurodegenerative diseases. Nat Rev Drug Discovery 24(4):276\u2013299","journal-title":"Nat Rev Drug Discovery"},{"key":"5991_CR33","doi-asserted-by":"crossref","unstructured":"Rajak A (2025) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Proteostasis: investigating molecular dynamics in neurodegenerative disorders. Springer, pp 371\u2013406","DOI":"10.1007\/978-981-96-6202-9_17"},{"key":"5991_CR34","doi-asserted-by":"crossref","unstructured":"Yuan C, Zhang J, Yao W, Qu M, Zhang L, Wang X, Liang M (2026) Bioengineered superoxide buffering extends lifespan via regulation of mitochondrial redox homeostasis and UPRmt activation.\u00a0Nano Res\u00a019(1):94908027","DOI":"10.26599\/NR.2025.94908027"},{"key":"5991_CR35","doi-asserted-by":"publisher","unstructured":"Kuwar OK, Dhingra MS, Maloo A et al (2026) The interplay between inflammation and oxidative stress in depression: pathogenic mechanisms and treatment approaches. Mol Biol Rep 53:239. https:\/\/doi.org\/10.1007\/s11033-025-11393-3","DOI":"10.1007\/s11033-025-11393-3"},{"key":"5991_CR36","doi-asserted-by":"publisher","unstructured":"Darfarin G, Pluth J (2025) Mitochondria-nuclear crosstalk: Orchestrating mtDNA maintenance. Environ Mol Mutagen 66(5):222\u2013242. https:\/\/doi.org\/10.1002\/em.70013","DOI":"10.1002\/em.70013"},{"issue":"2","key":"5991_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0271678X251341293","volume":"46","author":"X Chen","year":"2026","unstructured":"Chen X, An H, He J, Guo J, Xu S, Wu C, Wu D, Ji X (2026) Mitochondrial unfolded protein response (UPRmt) as novel therapeutic targets for neurological disorders. J Cereb Blood Flow Metab 46(2):333\u2013349","journal-title":"J Cereb Blood Flow Metab"},{"key":"5991_CR38","doi-asserted-by":"crossref","unstructured":"Yang H-M (2025) Mitochondrial dysfunction in neurodegenerative diseases. Cells 14(4):276","DOI":"10.3390\/cells14040276"},{"issue":"5","key":"5991_CR39","doi-asserted-by":"publisher","first-page":"e13796","DOI":"10.1111\/cpr.13796","volume":"58","author":"B Peng","year":"2025","unstructured":"Peng B, Wang Y, Zhang H (2025) Mitonuclear communication in stem cell function. Cell Prolif 58(5):e13796","journal-title":"Cell Prolif"},{"key":"5991_CR40","doi-asserted-by":"publisher","unstructured":"Maparu K, Chatterjee D, Kaur R et al (2025) Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implications. Med Oncol 42:131. https:\/\/doi.org\/10.1007\/s12032-025-02685-6","DOI":"10.1007\/s12032-025-02685-6"},{"issue":"12","key":"5991_CR41","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1016\/j.ymthe.2025.09.010","volume":"33","author":"Z Chen","year":"2025","unstructured":"Chen Z, Liu X, Zuo K, Xin Y, Liu J (2025) TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation. Mol Ther 33(12):6537\u20136553","journal-title":"Mol Ther"},{"key":"5991_CR42","doi-asserted-by":"crossref","unstructured":"Jurc\u0103u Mea, Jurc\u0103u A et al (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants (Basel) 11(11):2167","DOI":"10.3390\/antiox11112167"},{"key":"5991_CR43","doi-asserted-by":"crossref","unstructured":"Jurcau A (2021) Insights into the pathogenesis of neurodegenerative diseases: focus on mitochondrial dysfunction and oxidative stress. Int J Mol Sci 22(21):11847","DOI":"10.3390\/ijms222111847"},{"issue":"9","key":"5991_CR44","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.3390\/ijms26094451","volume":"26","author":"M Lucchesi","year":"2025","unstructured":"Lucchesi M et al (2025) Mitochondrial dysfunction in genetic and non-genetic Parkinson\u2019s Disease. Int J Mol Sci 26(9):4451","journal-title":"Int J Mol Sci"},{"key":"5991_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1636185","author":"Pea Lv","year":"2025","unstructured":"Lv Pea et al (2025) Spatiotemporal crosstalk among mitochondrial dynamics, NLRP3 inflammasome activation, and histone lactylation drives \u03b1-synuclein pathology in prodromal Parkinson\u2019s disease. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2025.1636185","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"5991_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/metabo15070461","volume":"15","author":"A Sawai","year":"2025","unstructured":"Sawai A et al (2025) ATP supply from cytosol to mitochondria is an additional role of aerobic glycolysis to prevent programmed cell death by maintenance of mitochondrial membrane potential. Metabolites 15(7):461","journal-title":"Metabolites"},{"issue":"5","key":"5991_CR47","first-page":"2695","volume":"16","author":"SK Soman","year":"2025","unstructured":"Soman SK, Woodruff MR, Dagda RK (2025) The mitochondrial foundations of Parkinson\u2019s disease: therapeutic implications. Aging Dis 16(5):2695","journal-title":"Aging Dis"},{"key":"5991_CR48","doi-asserted-by":"crossref","unstructured":"Rahman MA et al (2025) Oxidative stress in DNA damage and neurodegenerative diseases: unveiling the mechanisms and therapeutic opportunities. Cell Biochem Biophysics p. 1\u201320","DOI":"10.1007\/s12013-025-01845-9"},{"issue":"6","key":"5991_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/10915818251369414","volume":"44","author":"N Shah","year":"2025","unstructured":"Shah N, Saxena B, Gupta R (2025) Mitochondria: Key mediator for environmental toxicant\u2013induced neurodegeneration. Int J Toxicol 44(6):507\u2013525","journal-title":"Int J Toxicol"},{"issue":"6","key":"5991_CR50","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1007\/s12035-024-04526-5","volume":"62","author":"Mea Epifane-de-Assun\u00e7\u00e3o","year":"2025","unstructured":"Epifane-de-Assun\u00e7\u00e3o Mea et al (2025) Molecular alterations in core subunits of mitochondrial complex I and their relation to Parkinson\u2019s disease. Mol Neurobiol 62(6):6968\u20136982","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5991_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10571-025-01544-2","volume":"45","author":"S Yaribash","year":"2025","unstructured":"Yaribash S, Mohammadi K, Sani MA (2025) Alpha-synuclein pathophysiology in neurodegenerative disorders: a review focusing on molecular mechanisms and treatment advances in Parkinson\u2019s disease. Cell Mol Neurobiol 45(1):1\u201316","journal-title":"Cell Mol Neurobiol"},{"key":"5991_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103817","volume":"86","author":"PR Angelova","year":"2025","unstructured":"Angelova PR et al (2025) \u03b1-synuclein fibrils per se but not \u03b1-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons. Redox Biology 86:103817. https:\/\/doi.org\/10.1016\/j.redox.2025.103817","journal-title":"Redox Biology"},{"key":"5991_CR53","doi-asserted-by":"publisher","unstructured":"Wasim R (2025) Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer\u2019s disease. Inflammopharmacol 33:5273\u20135289. https:\/\/doi.org\/10.1007\/s10787-025-01916-6","DOI":"10.1007\/s10787-025-01916-6"},{"key":"5991_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106976","author":"Hea Brown","year":"2025","unstructured":"Brown Hea et al (2025) Imbalanced mitochondrial dynamics in human PD and \u03b1-synuclein mouse brains. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2025.106976","journal-title":"Neurobiol Dis"},{"key":"5991_CR55","doi-asserted-by":"publisher","first-page":"1481756","DOI":"10.3389\/fcell.2025.1481756","volume":"13","author":"Y Sun","year":"2025","unstructured":"Sun Y et al (2025) Harnessing exercise to combat chronic diseases: the role of Drp1-Mediated mitochondrial fission. Front Cell Dev Biol 13:1481756","journal-title":"Front Cell Dev Biol"},{"key":"5991_CR56","doi-asserted-by":"publisher","unstructured":"Rana A, Nikam T, Sreepathi B, Saraf SA, Awasthi S (2025) The aggregation continuum of \u03b1-synuclein and its relevance to brain aging.\u00a0ACS Chem Neurosci 16(19):3634\u201352.\u00a0https:\/\/doi.org\/10.1021\/acschemneuro.5c00356","DOI":"10.1021\/acschemneuro.5c00356"},{"key":"5991_CR57","doi-asserted-by":"crossref","unstructured":"Gallo-Soljancic Pea et al (2025) Dynamic changes in oxidative stress and epigenetic modifications in the ventral mesencephalon and striatum of MPTP-treated mice: implications for Parkinson\u2019s disease pathogenesis. Neurotox Res 43(4):30","DOI":"10.1007\/s12640-025-00748-0"},{"issue":"1","key":"5991_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/revneuro-2024-0080","volume":"36","author":"AA Mohamed Yusoff","year":"2025","unstructured":"Mohamed Yusoff AA, MohdKhair SZN (2025) Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases. Rev Neurosci 36(1):53\u201390","journal-title":"Rev Neurosci"},{"issue":"8","key":"5991_CR59","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.immuni.2025.07.012","volume":"58","author":"SE Weinberg","year":"2025","unstructured":"Weinberg SE, Chandel NS (2025) Mitochondria reactive oxygen species signaling in immune responses. Immunity 58(8):1904\u20131921","journal-title":"Immunity"},{"issue":"6","key":"5991_CR60","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1007\/s12035-024-04412-0","volume":"62","author":"Y Mishra","year":"2025","unstructured":"Mishra Y, Kumar A, Kaundal RK (2025) Mitochondrial dysfunction is a crucial immune checkpoint for neuroinflammation and neurodegeneration: mtdamps in focus. Mol Neurobiol 62(6):6715\u20136747","journal-title":"Mol Neurobiol"},{"issue":"7","key":"5991_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70213","volume":"13","author":"Lea Gong","year":"2025","unstructured":"Gong Lea, Gong L\u2010L et al (2025) Molecular mechanism of NLRP3 inflammasome in inflammatory diseases and tumors. Immun Inflamm Dis 13(7):e70213","journal-title":"Immun Inflamm Dis"},{"issue":"4","key":"5991_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","volume":"31","author":"Zea Zhou","year":"2024","unstructured":"Zhou Zea et al (2024) Diverse functions of cytochrome c in cell death and disease. Cell Death Differ 31(4):387\u2013404","journal-title":"Cell Death Differ"},{"issue":"10","key":"5991_CR63","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"M-Mea Lin","year":"2022","unstructured":"Lin M-Mea et al (2022) Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 43(10):2439\u20132447","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"5991_CR64","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1007\/s12035-021-02556-x","volume":"58","author":"Nea Sawant","year":"2021","unstructured":"Sawant Nea et al (2021) Mitochondrial abnormalities and synaptic damage in Huntington\u2019s disease: a focus on defective mitophagy and mitochondria-targeted therapeutics. Mol Neurobiol 58(12):6350\u20136377","journal-title":"Mol Neurobiol"},{"key":"5991_CR65","doi-asserted-by":"publisher","unstructured":"Fra\u0144czak M, Garga\u015b J, Sypecka J (2026) Mitochondria as a therapeutic target in neurodegeneration caused by hypoxia and ischemia during the perinatal period. Pharmacol Rep 78:1\u201326. https:\/\/doi.org\/10.1007\/s43440-025-00819-1","DOI":"10.1007\/s43440-025-00819-1"},{"issue":"18","key":"5991_CR66","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.3390\/app151810285","volume":"15","author":"JT Johnson","year":"2025","unstructured":"Johnson JT, Awosiminiala FW, Anumudu CK (2025) Exploring protein misfolding and aggregate pathology in neurodegenerative diseases: from molecular mechanisms to clinical interventions. Appl Sci 15(18):10285","journal-title":"Appl Sci"},{"issue":"2","key":"5991_CR67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"issue":"5","key":"5991_CR68","doi-asserted-by":"publisher","first-page":"e70378","DOI":"10.1111\/cns.70378","volume":"31","author":"Y Zhang","year":"2025","unstructured":"Zhang Y et al (2025) Mitochondria-associated membranes: a key point of neurodegenerative diseases. CNS Neurosci Ther 31(5):e70378","journal-title":"CNS Neurosci Ther"},{"key":"5991_CR69","doi-asserted-by":"publisher","first-page":"0912","DOI":"10.34133\/research.0912","volume":"8","author":"J Huang","year":"2025","unstructured":"Huang J et al (2025) Mitochondria metabolism regulates glucose\u2013lipid homeostasis in neurodegenerative diseases. Research 8:0912","journal-title":"Research"},{"key":"5991_CR70","doi-asserted-by":"crossref","unstructured":"Guan D, Liang C, Zheng D, Liu S, Luo J, Cai Z, Zhang H, Chen J (2025) The role of mitochondrial remodeling in neurodegenerative diseases. Neurochem Int 183:105927","DOI":"10.1016\/j.neuint.2024.105927"},{"key":"5991_CR71","doi-asserted-by":"crossref","unstructured":"Zerihun M, Sukumaran S, Qvit N (2023) The Drp1-mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy. Int J Mol Sci 24(6):5785","DOI":"10.3390\/ijms24065785"},{"issue":"6","key":"5991_CR72","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s11010-025-05209-y","volume":"480","author":"Yea Ding","year":"2025","unstructured":"Ding Yea et al (2025) Synaptic-mitochondrial transport: mechanisms in neural adaptation and degeneration. Mol Cell Biochem 480(6):3399\u20133411","journal-title":"Mol Cell Biochem"},{"key":"5991_CR73","doi-asserted-by":"crossref","unstructured":"Paul S, Kumar D, Pal A (2025) Relevance of synaptic plasticity and mitochondrial dysfunction in neurodegenerative disorders. Synaptic plasticity in neurodegenerative disorders. CRC Press, pp 39\u201360","DOI":"10.1201\/9781003464648-4"},{"issue":"5","key":"5991_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-025-04559-9","volume":"50","author":"V Walecha","year":"2025","unstructured":"Walecha V, Luthra PM (2025) The mitochondrial-astrocyte-neuron triad hypothesis in Parkinson\u2019s disease: a toxic feedback loop of metabolism, aggregation, and oxidative stress. Neurochem Res 50(5):1\u201319","journal-title":"Neurochem Res"},{"key":"5991_CR75","doi-asserted-by":"crossref","unstructured":"Bs P, Talwar P (2025) Influence of palmitoylation in axonal transport mechanisms in neurodegenerative diseases. Front Cell Neurosci 19:1613379, 1613379","DOI":"10.3389\/fncel.2025.1613379"},{"key":"5991_CR76","doi-asserted-by":"crossref","unstructured":"Murray-Cors Sea et al (2025) Impacts of mitochondrial dysfunction on axonal microtubule bundles as a potential mechanism of neurodegeneration. Front Neurosci 19:1631752, 1631752","DOI":"10.3389\/fnins.2025.1631752"},{"issue":"1","key":"5991_CR77","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/NRR.NRR-D-24-01019","volume":"21","author":"I Jahan","year":"2026","unstructured":"Jahan I et al (2026) Neuronal plasticity and its role in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neural Regen Res 21(1):107\u2013125","journal-title":"Neural Regen Res"},{"issue":"1","key":"5991_CR78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44324-025-00049-2","volume":"3","author":"F Borbolis","year":"2025","unstructured":"Borbolis F, Ploumi C, Palikaras K (2025) Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseases. npj Metabolic Health Dis 3(1):4","journal-title":"npj Metabolic Health Dis"},{"key":"5991_CR79","doi-asserted-by":"crossref","unstructured":"Lonobile Cea et al (2025) The mitochondrial permeability transition pore in platelets: mechanisms, physiological roles, and therapeutic perspectives. Antioxidants (Basel) 14(8):923, 923","DOI":"10.3390\/antiox14080923"},{"key":"5991_CR80","doi-asserted-by":"crossref","unstructured":"Kuwar OK, Singh S (2025) Baicalein-mediated regulation of Nrf2\/ARE, NF\u0138B, and MAPK signaling in Huntington\u2019s disease: a promising strategy against neuroinflammation and neurodegeneration. Inflammopharmacology p. 1\u201315","DOI":"10.1007\/s10787-025-01839-2"},{"key":"5991_CR81","doi-asserted-by":"crossref","unstructured":"Zhang Kea et al (2025) NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies. Front Aging Neurosci 17:1604378, 1604378","DOI":"10.3389\/fnagi.2025.1604378"},{"key":"5991_CR82","doi-asserted-by":"crossref","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(1):21","DOI":"10.1007\/s10048-025-00801-2"},{"issue":"1","key":"5991_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16213","volume":"169","author":"N Vassallo","year":"2025","unstructured":"Vassallo N (2025) Poration of mitochondrial membranes by amyloidogenic peptides and other biological toxins. J Neurochem 169(1):e16213","journal-title":"J Neurochem"},{"issue":"1","key":"5991_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12964-025-02416-4","volume":"23","author":"Z Zhuo","year":"2025","unstructured":"Zhuo Z et al (2025) Progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma. Cell Communication and Signaling 23(1):405","journal-title":"Cell Communication and Signaling"},{"issue":"2","key":"5991_CR85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/biomedicines13020327","volume":"13","author":"K Meng","year":"2025","unstructured":"Meng K et al (2025) Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies. Biomedicines 13(2):327","journal-title":"Biomedicines"},{"key":"5991_CR86","doi-asserted-by":"crossref","unstructured":"Kern C, Bonventre JV, Justin AW, Kashani K, Reynolds E, Siew K, Davis B, Karakoy H, Grzesiak N, Bailey DM (2025) Necrosis as a fundamental driver of loss of resilience and biological decline: what if we could intervene?. Oncogene 44(24):1893\u2013904","DOI":"10.1038\/s41388-025-03431-y"},{"issue":"5","key":"5991_CR87","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/antiox14050527","volume":"14","author":"N Abdukarimov","year":"2025","unstructured":"Abdukarimov N, Kokabi K, Kunz J (2025) Ferroptosis and iron homeostasis: molecular mechanisms and neurodegenerative disease implications. Antioxidants (Basel) 14(5):527","journal-title":"Antioxidants (Basel)"},{"key":"5991_CR88","doi-asserted-by":"publisher","first-page":"1615764","DOI":"10.3389\/fragi.2025.1615764","volume":"6","author":"S Mani","year":"2025","unstructured":"Mani S et al (2025) Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging. Front Aging 6:1615764","journal-title":"Front Aging"},{"issue":"5","key":"5991_CR89","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1007\/s12035-025-04687-x","volume":"62","author":"Hea Liu","year":"2025","unstructured":"Liu Hea et al (2025) The roles of DMT1 in inflammatory and degenerative diseases. Mol Neurobiol 62(5):6317\u20136332","journal-title":"Mol Neurobiol"},{"issue":"10","key":"5991_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-025-04544-y","volume":"41","author":"Z Zou","year":"2025","unstructured":"Zou Z et al (2025) Strategies for enhancing the adaptive response to oxidative stress in microbial cell factories. World J Microbiol Biotechnol 41(10):1\u201313","journal-title":"World J Microbiol Biotechnol"},{"key":"5991_CR91","doi-asserted-by":"crossref","unstructured":"Chang Jea et al (2025) Disulfidptosis: a new target for central nervous system disease therapy. Front Neurosci 19:1514253, 1514253","DOI":"10.3389\/fnins.2025.1514253"},{"issue":"3","key":"5991_CR92","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4103\/NRR.NRR-D-23-01343","volume":"20","author":"Y Shen","year":"2025","unstructured":"Shen Y et al (2025) Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer\u2019s disease. Neural Regen Res 20(3):613\u2013631","journal-title":"Neural Regen Res"},{"key":"5991_CR93","doi-asserted-by":"crossref","unstructured":"Shang X et al (2025) Do fungi also undergo\" ferroptosis\"? A microscopic exploration of cellular death. Apoptosis p. 1\u201316","DOI":"10.1007\/s10495-025-02164-3"},{"issue":"6","key":"5991_CR94","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/antiox14060656","volume":"14","author":"F Bellanti","year":"2025","unstructured":"Bellanti F et al (2025) Redox imbalance in inflammation: the interplay of oxidative and reductive stress. Antioxidants 14(6):656","journal-title":"Antioxidants"},{"issue":"13","key":"5991_CR95","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.3390\/ijms26136416","volume":"26","author":"MS Khan","year":"2025","unstructured":"Khan MS, Nasiripour S, Bopassa JC (2025) Parkinson disease signaling pathways, molecular mechanisms, and potential therapeutic strategies: a comprehensive review. Int J Mol Sci 26(13):6416","journal-title":"Int J Mol Sci"},{"key":"5991_CR96","doi-asserted-by":"crossref","unstructured":"Lee KS, Huh S, Lee S, Wu Z, Kim AK, Kang HY, Lu B (2018) Altered ER\u2013mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models. Proc Natl Acad Sci 115(38):E8844\u201353","DOI":"10.1073\/pnas.1721136115"},{"issue":"3","key":"5991_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5580","volume":"56","author":"Y Sun","year":"2025","unstructured":"Sun Y et al (2025) Lipid metabolism in microglia: emerging mechanisms and therapeutic opportunities for neurodegenerative diseases. Int J Mol Med 56(3):1\u201319","journal-title":"Int J Mol Med"},{"key":"5991_CR98","doi-asserted-by":"crossref","unstructured":"Selvaraj Nea et al (2025) Oxidative stress and redox imbalance: common mechanisms in cancer stem cells and neurodegenerative diseases. Cells (Basel) 14(7):511, 511","DOI":"10.3390\/cells14070511"},{"issue":"4","key":"5991_CR99","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/life15040577","volume":"15","author":"F D\u2019Egidio","year":"2025","unstructured":"D\u2019Egidio F et al (2025) Antioxidant and anti-inflammatory defenses in Huntington\u2019s disease: roles of NRF2 and PGC-1\u03b1, and therapeutic strategies. Life 15(4):577","journal-title":"Life"},{"issue":"1","key":"5991_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","volume":"20","author":"S Quan","year":"2025","unstructured":"Quan S et al (2025) The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer\u2019s disease. Mol Neurodegener 20(1):25","journal-title":"Mol Neurodegener"},{"issue":"12","key":"5991_CR101","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.4103\/NRR.NRR-D-24-00630","volume":"20","author":"Yea Peng","year":"2025","unstructured":"Peng Yea et al (2025) Calcium bridges built by mitochondria-associated endoplasmic reticulum membranes: potential targets for neural repair in neurological diseases. Neural Regen Res 20(12):3349\u20133369","journal-title":"Neural Regen Res"},{"key":"5991_CR102","doi-asserted-by":"crossref","unstructured":"Paidi C, Nuthalapati Y, Samudrala AS, Bhamidipati P, Mangam C, Welch DR, Nagaraju GP, Malla R (2025) ER-mitochondria tethering and its signaling: A novel therapeutic target in breast cancer. Mol Ther Oncol 33(2)","DOI":"10.1016\/j.omton.2025.200995"},{"key":"5991_CR103","doi-asserted-by":"crossref","unstructured":"Truong Tea et al (2025) Mitochondria-associated membrane dysfunction in neurodegeneration and its effects on lipid metabolism, calcium signaling, and cell fate. Membranes (Basel) 15(9):263, 263","DOI":"10.3390\/membranes15090263"},{"key":"5991_CR104","doi-asserted-by":"crossref","unstructured":"Gouri H, Bararia Y, Malhotra V (2025) The mitochondrial interactome in Parkinson\u2019s and Huntington\u2019s diseases. Nat Cell Sci 3(3)","DOI":"10.61474\/ncs.2025.00017"},{"issue":"1","key":"5991_CR105","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther 10(1):190","journal-title":"Signal Transduct Target Ther"},{"key":"5991_CR106","doi-asserted-by":"crossref","unstructured":"Olaru Gea et al (2025) Harnessing mitochondrial function for post-stroke rehabilitation: unlocking antioxidant power. Antioxidants (Basel) 14(9):1080, 1080","DOI":"10.3390\/antiox14091080"},{"issue":"9","key":"5991_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30091972","volume":"30","author":"Yea Wang","year":"2025","unstructured":"Wang Yea et al (2025) Advances in \u03b1-lipoic acid for disease prevention: mechanisms and therapeutic insights. Molecules 30(9):1972","journal-title":"Molecules"},{"key":"5991_CR108","doi-asserted-by":"crossref","unstructured":"Manful Cea et al (2025) Therapeutic strategies targeting oxidative stress and inflammation: a narrative review. BioChem 5(4):35, 35","DOI":"10.3390\/biochem5040035"},{"key":"5991_CR109","doi-asserted-by":"publisher","unstructured":"Kuwar OK, Kalia N (2025) Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF\u0138B in neurodegenerative disease. Inflammopharmacol 33:1303\u20131310. https:\/\/doi.org\/10.1007\/s10787-025-01698-x","DOI":"10.1007\/s10787-025-01698-x"},{"issue":"1","key":"5991_CR110","doi-asserted-by":"publisher","first-page":"8832992","DOI":"10.1155\/jare\/8832992","volume":"2025","author":"S Hamidu","year":"2025","unstructured":"Hamidu S et al (2025) Modulating ferroptosis in aging: the therapeutic potential of natural products. J Aging Res 2025(1):8832992","journal-title":"J Aging Res"},{"issue":"1","key":"5991_CR111","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s11033-025-10947-9","volume":"52","author":"C Shandilya","year":"2025","unstructured":"Shandilya C, Mani S (2025) Rho kinase isoforms in neurodegeneration: from cellular functions to therapeutic targets. Mol Biol Rep 52(1):846","journal-title":"Mol Biol Rep"},{"key":"5991_CR112","doi-asserted-by":"crossref","unstructured":"Minami S, Nakamura S, Yoshimori T (2025) Autophagy and intracellular membrane dynamics in aging and age-related diseases. Autophagy-from molecular mechanisms to flux control in health and disease. Springer, pp 171\u2013211","DOI":"10.1007\/978-3-031-88121-3_7"},{"issue":"14","key":"5991_CR113","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.3390\/ijms26146833","volume":"26","author":"NA Kamar Bashah","year":"2025","unstructured":"Kamar Bashah NA et al (2025) Role of AMP-activated protein kinase (AMPK) in female reproduction: a review. Int J Mol Sci 26(14):6833","journal-title":"Int J Mol Sci"},{"key":"5991_CR114","doi-asserted-by":"crossref","unstructured":"Zhang J, Wang HL, Lautrup S, Nilsen HL, Treebak JT, Watne LO, Selb\u00e6k G, Wu LE, Omland T, Pirinen E, Cheung TC (2025) Emerging strategies, applications and challenges of targeting NAD+ in the clinic. Nat Aging 5(9):1704\u201331","DOI":"10.1038\/s43587-025-00947-6"},{"issue":"3","key":"5991_CR115","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/01652176.2014.924642","volume":"34","author":"Yea Sun","year":"2014","unstructured":"Sun Yea et al (2014) Characterization of the serum metabolic profile of dairy cows with milk fever using 1H-NMR spectroscopy. Vet Q 34(3):159\u2013163","journal-title":"Vet Q"},{"key":"5991_CR116","doi-asserted-by":"crossref","unstructured":"Paw\u0142owska Mea et al (2025) Ketogenic metabolism in neurodegenerative diseases: mechanisms of action and therapeutic potential. Metabolites 15(8):508, 508","DOI":"10.3390\/metabo15080508"},{"key":"5991_CR117","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s549893","author":"L Gao","year":"2025","unstructured":"Gao L, Wang J, Bi Y (2025) Nanotechnology for neurodegenerative diseases: recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/ijn.s549893","journal-title":"Int J Nanomedicine"},{"key":"5991_CR118","doi-asserted-by":"crossref","unstructured":"Budinger D, Alhaque S, Gonz\u00e1lez-M\u00e9ndez R, Dadswell C, Barwick K, Ferrini A, Roth C, McCann CJ, Tuschl K, Al Jasmi F, Zaki MS (2025) An iPSC-derived neuronal model reveals manganese\u2019s role in neuronal endocytosis, calcium flux and mitochondrial bioenergetics. IScience 28(9)","DOI":"10.1016\/j.isci.2025.113311"},{"key":"5991_CR119","first-page":"1","volume-title":"Industrial crops improvement: biotechnological approaches for sustainable agricultural development","author":"SR Salunkhe","year":"2025","unstructured":"Salunkhe SR et al (2025) Applications and potential of genome editing in industrial crop improvement. Industrial crops improvement: biotechnological approaches for sustainable agricultural development. Springer, pp 1\u201319"},{"key":"5991_CR120","doi-asserted-by":"publisher","unstructured":"Chen J et al (2025) Mitochondria transfer in mesenchymal stem cells: unraveling the mechanism and therapeutic potential.\u00a0Curr Stem Cell Res Ther 20(11):1153\u20131173.\u00a0https:\/\/doi.org\/10.2174\/011574888x362739250416153254","DOI":"10.2174\/011574888x362739250416153254"},{"key":"5991_CR121","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12979-025-00522-y","volume":"22","author":"M Ahmed","year":"2025","unstructured":"Ahmed M (2025) Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol. Immunity Ageing: I A 22:28","journal-title":"Immunity Ageing: I A"},{"issue":"4","key":"5991_CR122","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/ptr.8156","volume":"38","author":"Hea Liang","year":"2024","unstructured":"Liang Hea et al (2024) Regulation of mitophagy and mitochondrial function: natural compounds as potential therapeutic strategies for Parkinson\u2019s disease. Phytother Res 38(4):1838\u20131862","journal-title":"Phytother Res"},{"issue":"4","key":"5991_CR123","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/neuroglia5040026","volume":"5","author":"D Ghosh","year":"2024","unstructured":"Ghosh D, Kumar A (2024) Harnessing mitophagy for therapeutic advances in aging and chronic neurodegenerative diseases. Neuroglia 5(4):391\u2013409","journal-title":"Neuroglia"},{"key":"5991_CR124","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2022.07.007","volume":"499","author":"L Rani","year":"2022","unstructured":"Rani L, Sahu MR, Mondal AC (2022) Age-related mitochondrial dysfunction in Parkinson\u2019s disease: new insights into the disease pathology. Neuroscience 499:152\u2013169","journal-title":"Neuroscience"},{"key":"5991_CR125","doi-asserted-by":"publisher","first-page":"104631","DOI":"10.1016\/j.nbd.2019.104631","volume":"134","author":"C Chen","year":"2020","unstructured":"Chen C et al (2020) Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues. Neurobiol Dis 134:104631","journal-title":"Neurobiol Dis"},{"issue":"7","key":"5991_CR126","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/s41380-020-00999-7","volume":"26","author":"Aea de Rus Jacquet","year":"2021","unstructured":"de Rus Jacquet Aea et al (2021) Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders. Mol Psychiatry 26(7):2685\u20132706","journal-title":"Mol Psychiatry"},{"issue":"11","key":"5991_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/genes13111937","volume":"13","author":"Jea Kim","year":"2022","unstructured":"Kim Jea et al (2022) Human induced pluripotent stem cell phenotyping and preclinical modeling of familial Parkinson\u2019s disease. Genes 13(11):1937","journal-title":"Genes"},{"issue":"3","key":"5991_CR128","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","volume":"135","author":"Iea Fl\u00f8nes","year":"2018","unstructured":"Fl\u00f8nes Iea et al (2018) Neuronal complex I deficiency occurs throughout the Parkinson\u2019s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathol 135(3):409\u2013425","journal-title":"Acta Neuropathol"},{"issue":"11","key":"5991_CR129","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/jcm6110100","volume":"6","author":"M Al Shahrani","year":"2017","unstructured":"Al Shahrani M et al (2017) Oxidative stress: mechanistic insights into inherited mitochondrial disorders and Parkinson\u2019s disease. J Clin Med 6(11):100","journal-title":"J Clin Med"},{"key":"5991_CR130","doi-asserted-by":"crossref","unstructured":"Schirinzi Tea et al (2022) Pattern of mitochondrial respiration in peripheral blood cells of patients with Parkinson\u2019s disease. Int J Mol Sci 23(18):10863, 10863","DOI":"10.3390\/ijms231810863"},{"issue":"10","key":"5991_CR131","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"33","author":"Aea Smith","year":"2018","unstructured":"Smith Aea et al (2018) Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov Disord 33(10):1580\u20131590","journal-title":"Mov Disord"},{"issue":"2","key":"5991_CR132","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biomedicines12020282","volume":"12","author":"KA Kritskaya","year":"2024","unstructured":"Kritskaya KA, Fedotova EI, Berezhnov AV (2024) Impaired mitochondrial network morphology and reactive oxygen species production in fibroblasts from Parkinson\u2019s disease patients. Biomedicines 12(2):282","journal-title":"Biomedicines"},{"issue":"1","key":"5991_CR133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-022-00308-y","volume":"11","author":"MA Olesen","year":"2022","unstructured":"Olesen MA, Villavicencio-Tejo F, Quintanilla RA (2022) The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. Transl Neurodegener 11(1):36","journal-title":"Transl Neurodegener"},{"issue":"4","key":"5991_CR134","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/s12035-018-1206-6","volume":"56","author":"SM Yakhine-Diop","year":"2019","unstructured":"Yakhine-Diop SM et al (2019) Impaired mitophagy and protein acetylation levels in fibroblasts from Parkinson\u2019s disease patients. Mol Neurobiol 56(4):2466\u20132481","journal-title":"Mol Neurobiol"},{"key":"5991_CR135","doi-asserted-by":"publisher","unstructured":"Beccano-Kelly DA, Cherubini M, Mousba Y, Cramb KM, Giussani S, Caiazza MC, Rai P, Vingill S, Bengoa-Vergniory N, Ng B, Corda G (2023) Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson\u2019s iPSC-dopamine neurons. IScience 26(7).\u00a0https:\/\/doi.org\/10.1016\/j.isci.2023.107044","DOI":"10.1016\/j.isci.2023.107044"},{"issue":"4","key":"5991_CR136","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SY Chung","year":"2016","unstructured":"Chung SY et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-synuclein accumulation. Stem Cell Rep 7(4):664\u2013677","journal-title":"Stem Cell Rep"},{"key":"5991_CR137","doi-asserted-by":"crossref","unstructured":"Li Hea, Li A et al (2019) Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations. Autophagy 15(1):113\u2013130","DOI":"10.1080\/15548627.2018.1509818"},{"key":"5991_CR138","doi-asserted-by":"crossref","unstructured":"Imaizumi Yea et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5(1):35, 35","DOI":"10.1186\/1756-6606-5-35"},{"key":"5991_CR139","unstructured":"Singh V (2024) Advancements and applications of MR spectroscopy in neuroimaging: a comprehensive review. Int J Med Sci Clin Res Rev 7(4):730\u201350"},{"issue":"1","key":"5991_CR140","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1196\/annals.1427.037","volume":"1147","author":"C Henchcliffe","year":"2008","unstructured":"Henchcliffe C et al (2008) Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson\u2019s disease. Ann N Y Acad Sci 1147(1):206\u2013220","journal-title":"Ann N Y Acad Sci"},{"key":"5991_CR141","doi-asserted-by":"crossref","unstructured":"Miceli Aea et al (2020) 18F-Fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress. Int J Mol Sci 21(21):8154, 8154","DOI":"10.3390\/ijms21218154"},{"issue":"10","key":"5991_CR142","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/antiox13101226","volume":"13","author":"Y Zhu","year":"2024","unstructured":"Zhu Y et al (2024) PET Imaging with [18F] ROStrace detects oxidative stress and predicts Parkinson\u2019s disease progression in mice. Antioxidants 13(10):1226","journal-title":"Antioxidants"},{"key":"5991_CR143","doi-asserted-by":"crossref","unstructured":"Qi Hea et al (2021) Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP\/MPP+-induced Parkinson\u2019s disease. Neurosci Lett 741:135493, 135493","DOI":"10.1016\/j.neulet.2020.135493"},{"key":"5991_CR144","doi-asserted-by":"crossref","unstructured":"Payne T, Appleby M, Buckley E, van Gelder LM, Mullish BH, Sassani M, Dunning MJ, Hernandez D, Scholz SW, McNeill A, Libri V (2023) A double\u2010blind, randomized, placebo\u2010controlled trial of ursodeoxycholic acid (UDCA) in Parkinson's disease.\u00a0Mov Disord\u00a038(8):1493\u2013502","DOI":"10.1002\/mds.29450"},{"issue":"3","key":"5991_CR145","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JPD-202128","volume":"10","author":"K McFarthing","year":"2020","unstructured":"McFarthing K et al (2020) Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2020. J Parkinson\u2019s Dis 10(3):757\u2013774","journal-title":"J Parkinson\u2019s Dis"},{"key":"5991_CR146","doi-asserted-by":"publisher","unstructured":"Dhawan V, Peng S, Spetsieris PG, Eidelberg D, Ma Y (2025) Positron emission tomography imaging in clinical trials for Parkinson's disease: applications of metabolic brain network approach. Movement Disorders 40(8):1511\u201327.\u00a0https:\/\/doi.org\/10.1002\/mds.30231","DOI":"10.1002\/mds.30231"},{"key":"5991_CR147","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.11.022","volume":"94","author":"Jea Schultz","year":"2022","unstructured":"Schultz Jea et al (2022) A pilot to assess target engagement of terazosin in Parkinson\u2019s disease. Parkinsonism Relat Disord 94:79\u201383","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"5991_CR148","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s12640-022-00579-3","volume":"40","author":"Uea Naeem","year":"2022","unstructured":"Naeem Uea et al (2022) Glycolysis: the next big breakthrough in Parkinson\u2019s disease. Neurotox Res 40(6):1707\u20131717","journal-title":"Neurotox Res"},{"issue":"1","key":"5991_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-025-02341-6","volume":"23","author":"L L\u00f3pez-Molina","year":"2025","unstructured":"L\u00f3pez-Molina L et al (2025) Mitochondria from Huntington\u00b4 s disease striatal astrocytes are hypermetabolic and compromise neuronal branching. Cell Commun Signaling 23(1):1\u201323","journal-title":"Cell Commun Signaling"},{"issue":"3","key":"5991_CR150","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/ijms26031248","volume":"26","author":"O Buneeva","year":"2025","unstructured":"Buneeva O, Medvedev A (2025) Monoamine oxidase inhibitors in toxic models of Parkinsonism. Int J Mol Sci 26(3):1248","journal-title":"Int J Mol Sci"},{"key":"5991_CR151","doi-asserted-by":"crossref","unstructured":"Bhimanwar AA, Kulkarni AS, Gomase VS (2025) The role of animal models in Huntington's disease clinical trials: decoding genetic, non-genetic, and molecular pathways. Rev Recent Clin Trials","DOI":"10.2174\/0115748871372165250625212002"},{"key":"5991_CR152","doi-asserted-by":"crossref","unstructured":"Mondal S, Firdous SM (2025) Unrevealing the molecular mechanisms of MPTP-induced Parkinson\u2019s in experimental animals. Med Chem Res 34(12):2398\u2013413","DOI":"10.1007\/s00044-025-03409-1"},{"key":"5991_CR153","doi-asserted-by":"crossref","unstructured":"Wen Yea et al (2025) Endoplasmic reticulum stress inhibition promotes mitophagy via Miro1 reduction to rescue mitochondrial dysfunction and protect dopamine neurons in Parkinson\u2019s disease. Cell Mol Neurobiol 45(1):53","DOI":"10.1007\/s10571-025-01575-9"},{"key":"5991_CR154","doi-asserted-by":"publisher","first-page":"1568002","DOI":"10.3389\/fnagi.2025.1568002","volume":"17","author":"L Huang","year":"2025","unstructured":"Huang L et al (2025) Galangin reduces MPTP-induced dopamine neuron injury via the autophagy dependent-PI3K\/AKT pathway. Front Aging Neurosci 17:1568002","journal-title":"Front Aging Neurosci"},{"key":"5991_CR155","doi-asserted-by":"crossref","unstructured":"Kumar R, Arora S, Alam S, Rashid M, Kumar S (2025) \u03b1-Phellandrene: A promising natural remedy for rotenone-induced Parkinson's disease. Recent Advances in Food, Nutrition & Agriculture","DOI":"10.2174\/012772574X341801241218051720"},{"issue":"1","key":"5991_CR156","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/20905068.2024.2431338","volume":"61","author":"MR Riad","year":"2025","unstructured":"Riad MR, Abdelghany AH, Salah NM (2025) Assessment of neurotoxicity of rotenone and the possible protective effect of alpha lipoic acid in adult male albino rats. Alexandria J Med 61(1):67\u201379","journal-title":"Alexandria J Med"},{"key":"5991_CR157","doi-asserted-by":"crossref","unstructured":"Chen W-L, Deng F-S, Tsai Y-C (2025) Lactiplantibacillus plantarum as a psychobiotic strategy targeting Parkinson\u2019s disease: a review and mechanistic insights. Nutrients 17(19):3047, 3047","DOI":"10.3390\/nu17193047"},{"key":"5991_CR158","doi-asserted-by":"crossref","unstructured":"Delgado-Minjares KM, Martinez-Fong D, Mart\u00ednez-D\u00e1vila IA, Ba\u00f1uelos C, Gutierrez-Castillo ME, Blanco-Alvarez VM, Cardenas-Aguayo MD, Luna-Mu\u00f1oz J, Pacheco-Herrero M, Soto-Rojas LO (2021) Mechanistic insight from preclinical models of Parkinson\u2019s disease could help redirect clinical trial efforts in GDNF therapy. Int J Mol Sci 22(21):11702","DOI":"10.3390\/ijms222111702"},{"key":"5991_CR159","doi-asserted-by":"crossref","unstructured":"Ibiayo Aea et al (2025) Coniferaldehyde reverses 3-nitropropionic acid-induced Huntington\u2019s disease pathologies via PKM2 restoration and JAK2\/STAT3 inhibition. Mol Med 31(1):271","DOI":"10.1186\/s10020-025-01308-0"},{"issue":"1","key":"5991_CR160","doi-asserted-by":"publisher","first-page":"23356","DOI":"10.1038\/s41598-025-07181-5","volume":"15","author":"SK Alenezi","year":"2025","unstructured":"Alenezi SK (2025) Barbigerone attenuates 3-nitropropionic acid-induced Huntington\u2019s disease-like neuropathology in rats via antioxidant, anti-inflammatory, and neuroprotective mechanisms. Sci Rep 15(1):23356","journal-title":"Sci Rep"},{"issue":"3","key":"5991_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-025-04397-9","volume":"50","author":"M Rabie","year":"2025","unstructured":"Rabie M et al (2025) Oxytocin anti-apoptotic potential mediates neuroprotection against 3-nitropropionic acid-induced Huntington\u2019s disease-like pathophysiology in rats: involvement of Calpain-2\/p25 Cdk5\/MEF-2 signaling pathway. Neurochem Res 50(3):1\u201315","journal-title":"Neurochem Res"},{"issue":"3","key":"5991_CR162","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/metabo15030210","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Diverse physiological roles of kynurenine pathway metabolites: updated implications for health and disease. Metabolites 15(3):210","journal-title":"Metabolites"},{"key":"5991_CR163","doi-asserted-by":"crossref","unstructured":"Khoshnan A (2024) Gut microbiota as a modifier of Huntington\u2019s disease pathogenesis. J Huntington's Dis 13(2):133\u201347","DOI":"10.3233\/JHD-240012"},{"issue":"1","key":"5991_CR164","doi-asserted-by":"publisher","first-page":"978","DOI":"10.15212\/bioi-2025-0073","volume":"6","author":"I Debnath","year":"2025","unstructured":"Debnath I et al (2025) Mechanistic insights and therapeutic potential of quercetin in neuroprotection: a comprehensive review of pathways and clinical perspectives. BIO Integration 6(1):978","journal-title":"BIO Integration"},{"key":"5991_CR165","doi-asserted-by":"crossref","unstructured":"Rubio C, Serrano-Garc\u00edA N, Taddei E, Casta\u00f1Eda E, Romo H, Rubio-Osornio M (2025) Rotenone-induced mitochondrial dysfunction, neuroinflammation, oxidative stress, and glial activation in Parkinson\u2019s and Alzheimer\u2019s diseases. Biocell 49(8):1391\u2013412","DOI":"10.32604\/biocell.2025.066320"},{"key":"5991_CR166","doi-asserted-by":"crossref","unstructured":"Wu WL, Gong XX, Qin ZH, Wang Y (2025) Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update. Acta Pharmacol Sin 46(12):3129\u201342","DOI":"10.1038\/s41401-025-01576-w"},{"issue":"21","key":"5991_CR167","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.3390\/ijms232113043","volume":"23","author":"LP Dolgacheva","year":"2022","unstructured":"Dolgacheva LP, Zinchenko VP, Goncharov NV (2022) Molecular and cellular interactions in pathogenesis of sporadic Parkinson disease. Int J Mol Sci 23(21):13043","journal-title":"Int J Mol Sci"},{"key":"5991_CR168","doi-asserted-by":"crossref","unstructured":"Leeming PJ, Mercuri-Svik J, Stojanovski D. From biogenesis to breakdown: how protein biogenesis and quality control failures drive mitochondrial disease.\u00a0Mol Cell Biol\u00a046(1):21\u201347","DOI":"10.1080\/10985549.2025.2566671"},{"issue":"1","key":"5991_CR169","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY-Y Pang","year":"2019","unstructured":"Pang SY-Y et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8(1):23","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5991_CR170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JHD-200429","volume":"10","author":"DG Monckton","year":"2021","unstructured":"Monckton DG (2021) The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: a historical perspective. J Huntington Dis 10(1):7\u201333","journal-title":"J Huntington Dis"},{"issue":"7","key":"5991_CR171","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau CM (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 18(7):1472\u20131477","journal-title":"Neural Regen Res"},{"key":"5991_CR172","doi-asserted-by":"crossref","unstructured":"Sharma Aea, Sharma L et al (2021) Mitochondrial dysfunction in Huntington\u2019s disease: pathogenesis and therapeutic opportunities. Curr Drug Targets 22(14):1637\u20131667","DOI":"10.2174\/1389450122666210224105945"},{"key":"5991_CR173","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1016\/S1353-8020(09)70812-0","volume":"15","author":"MF Beal","year":"2009","unstructured":"Beal MF (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord 15:S189\u2013S194","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"5991_CR174","doi-asserted-by":"publisher","first-page":"e70107","DOI":"10.1111\/bcpt.70107","volume":"137","author":"E Eroglu","year":"2025","unstructured":"Eroglu E, Harmanci N (2025) Emerging molecular targets in neurodegenerative disorders: new avenues for therapeutic intervention. Basic Clin Pharmacol Toxicol 137(4):e70107","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"5991_CR175","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","volume":"24","author":"SR Bacman","year":"2018","unstructured":"Bacman SR, Kauppila JH, Pereira CV, Nissanka N, Miranda M, Pinto M, Williams SL, Larsson N-Gea, et al. (2018) MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation. Nat Med 24(11):1696\u20131700","journal-title":"Nat Med"},{"key":"5991_CR176","unstructured":"Bafadam S, Mokhtari B, Alihemmati A, Badalzadeh R (2025) Effects of combo therapy with coenzyme Q10 and mitochondrial transplantation on myocardial ischemia\/reperfusion-induced arrhythmias in aged rats. Iran J Basic Med Sci 28(1):38"},{"issue":"5","key":"5991_CR177","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515\u2013517","journal-title":"Nat Genet"},{"issue":"8","key":"5991_CR178","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10571-009-9411-5","volume":"29","author":"J Bournival","year":"2009","unstructured":"Bournival J, Quessy P, Martinoli M-G (2009) Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 29(8):1169\u20131180","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"5991_CR179","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Cant\u00f3","year":"2015","unstructured":"Cant\u00f3 C, Menzies KJ, Auwerx J (2015) NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 22(1):31\u201353","journal-title":"Cell Metab"},{"issue":"3","key":"5991_CR180","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive Mea et al (2019) Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412","journal-title":"Nat Neurosci"},{"issue":"2","key":"5991_CR181","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","volume":"34","author":"PA Gammage","year":"2018","unstructured":"Gammage PA, Moraes CT, Minczuk M (2018) Mitochondrial genome engineering: the revolution may not be CRISPR-Ized. Trends Genet 34(2):101\u2013110","journal-title":"Trends Genet"},{"key":"5991_CR182","doi-asserted-by":"publisher","first-page":"1505867","DOI":"10.3389\/fphar.2024.1505867","volume":"15","author":"D Ji","year":"2025","unstructured":"Ji D, Mylvaganam S, Ravi Chander P, Tarnopolsky M, Murphy K, Carlen P (2025) Mitochondria and oxidative stress in epilepsy: advances in antioxidant therapy. Front Pharmacol 15:1505867","journal-title":"Front Pharmacol"},{"key":"5991_CR183","doi-asserted-by":"publisher","first-page":"343748","DOI":"10.1016\/j.aca.2025.343748","volume":"1345","author":"H Jia","year":"2025","unstructured":"Jia H, Wang C, Fu Y, Wang Y, Zhang X, Tang Y, Ding J, He K et al (2025) Visualization of mitochondrial molecular dynamics during mitophagy process by label-free surface-enhanced Raman scattering spectroscopy. Anal Chim Acta 1345:343748","journal-title":"Anal Chim Acta"},{"key":"5991_CR184","doi-asserted-by":"crossref","unstructured":"Shafie A, Ashour AA, Anwar S, Anjum F, Hassan MI (2024) Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington\u2019s disease. Arch Pharmacal Res 47(6):571\u201395","DOI":"10.1007\/s12272-024-01499-w"},{"key":"5991_CR185","doi-asserted-by":"crossref","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021) Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9(8):918, 918","DOI":"10.3390\/biomedicines9080918"},{"key":"5991_CR186","doi-asserted-by":"crossref","unstructured":"Lopez-Toledo G, Silva-Lucero M-d-C, Herrera-D\u00edaz J, Garc\u00eda D-E, Arias-Monta\u00f1o J-A, Cardenas-Aguayo M-d-C (2022) Patient-derived fibroblasts with presenilin-1 mutations, that model aspects of Alzheimer\u2019s disease pathology, constitute a potential object for early diagnosis. Front Aging Neurosci 14:921573, 921573","DOI":"10.3389\/fnagi.2022.921573"},{"key":"5991_CR187","doi-asserted-by":"crossref","unstructured":"Luque-Campos N, Riquelme R, Molina L, Canedo-Marroqu\u00edn G, Vega-Letter AM, Luz-Crawford P, Bustamante-Barrientos FA (2023) Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration. Front Physiol 14:1217815, 1217815","DOI":"10.3389\/fphys.2023.1278208"},{"issue":"9","key":"5991_CR188","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras K, Lionaki E, Tavernarakis N (2018) Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol 20(9):1013\u20131022","journal-title":"Nat Cell Biol"},{"key":"5991_CR189","doi-asserted-by":"crossref","unstructured":"Shtilbans A, Esneault E, Simon F, Mazzulli JR, Quiriconi DJ, Rom D, Reintsch WE, Krahn Aea et al (2025) Evaluation of additive neuroprotective effect of combination therapy for Parkinson\u2019s disease using in vitro models. Antioxidants (Basel) 14(4):396, 396","DOI":"10.3390\/antiox14040396"},{"issue":"8","key":"5991_CR190","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24(8):1583","journal-title":"Molecules"},{"issue":"7","key":"5991_CR191","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B et al (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637\u2013649","journal-title":"Lancet Neurol"},{"issue":"5","key":"5991_CR192","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Flint Beal M (2009) Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 109(5):1427\u20131439","journal-title":"J Neurochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05991-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:03:25Z","timestamp":1781089405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05991-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":192,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5991"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05991-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"685"}}